Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease.

Catt H, Bodger K, Kirkham JJ, Hughes DA.

Pharmacoeconomics. 2019 Aug 2. doi: 10.1007/s40273-019-00826-0. [Epub ahead of print]

PMID:
31372948
2.

Industry funding was associated with increased use of core outcome sets.

Kirkham JJ, Bracken M, Hind L, Pennington K, Clarke M, Williamson PR.

J Clin Epidemiol. 2019 Jul 18;115:90-97. doi: 10.1016/j.jclinepi.2019.07.007. [Epub ahead of print]

PMID:
31326541
3.

Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies.

Richardson M, Kirkham JJ, Dwan KM, Sloan DJ, Davies G, Jorgensen A.

BMJ Open. 2019 Jul 11;9(7):e030212. doi: 10.1136/bmjopen-2019-030212.

4.

Scoping review on interventions to improve adherence to reporting guidelines in health research.

Blanco D, Altman D, Moher D, Boutron I, Kirkham JJ, Cobo E.

BMJ Open. 2019 May 9;9(5):e026589. doi: 10.1136/bmjopen-2018-026589.

5.

Empirical comparison of univariate and multivariate meta-analyses in Cochrane Pregnancy and Childbirth reviews with multiple binary outcomes.

Price MJ, Blake HA, Kenyon S, White IR, Jackson D, Kirkham JJ, Neilson JP, Deeks JJ, Riley RD.

Res Synth Methods. 2019 May 6. doi: 10.1002/jrsm.1353. [Epub ahead of print]

PMID:
31058440
6.

Improvement was needed in the standards of development for cancer core outcome sets.

Gargon E, Williamson PR, Blazeby JM, Kirkham JJ.

J Clin Epidemiol. 2019 Aug;112:36-44. doi: 10.1016/j.jclinepi.2019.04.006. Epub 2019 Apr 19.

7.

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.

Chiarotto A, Kaiser U, Choy E, Christensen R, Conaghan PG, Cowern M, Gill M, de Wit M, Gargon E, Horgan B, Kirkham JJ, Simon LS, Singh JA, Tugwell P, Turk DC, Mease PJ.

J Rheumatol. 2019 Apr 1. pii: jrheum.181099. doi: 10.3899/jrheum.181099. [Epub ahead of print]

PMID:
30936284
8.

Systematic review: outcomes and adverse events from randomised trials in Crohn's disease.

Catt H, Hughes D, Kirkham JJ, Bodger K.

Aliment Pharmacol Ther. 2019 Apr;49(8):978-996. doi: 10.1111/apt.15174. Epub 2019 Mar 3. Review.

9.

Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement.

Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR; COS-STAP Group.

Trials. 2019 Feb 11;20(1):116. doi: 10.1186/s13063-019-3230-x.

10.

Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews.

Kirkham JJ, Altman DG, Chan AW, Gamble C, Dwan KM, Williamson PR.

BMJ. 2018 Sep 28;362:k3802. doi: 10.1136/bmj.k3802. No abstract available.

11.

Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study.

Meher S, Cuthbert A, Kirkham JJ, Williamson P, Abalos E, Aflaifel N, Bhutta ZA, Bishop A, Blum J, Collins P, Devane D, Ducloy-Bouthors AS, Fawole B, Gülmezoglu AM, Gutteridge K, Gyte G, Homer C, Mallaiah S, Smith JM, Weeks AD, Alfirevic Z.

BJOG. 2019 Jan;126(1):83-93. doi: 10.1111/1471-0528.15335. Epub 2018 Jul 29.

PMID:
29920912
12.

Interventions to improve adherence to reporting guidelines in health research: a scoping review protocol.

Blanco D, Kirkham JJ, Altman DG, Moher D, Boutron I, Cobo E.

BMJ Open. 2017 Nov 16;7(11):e017551. doi: 10.1136/bmjopen-2017-017551. Review.

13.

Core Outcome Set-STAndards for Development: The COS-STAD recommendations.

Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR.

PLoS Med. 2017 Nov 16;14(11):e1002447. doi: 10.1371/journal.pmed.1002447. eCollection 2017 Nov.

14.

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.

McCann LJ, Pilkington CA, Huber AM, Ravelli A, Appelbe D, Kirkham JJ, Williamson PR, Aggarwal A, Christopher-Stine L, Constantin T, Feldman BM, Lundberg I, Maillard S, Mathiesen P, Murphy R, Pachman LM, Reed AM, Rider LG, van Royen-Kerkof A, Russo R, Spinty S, Wedderburn LR, Beresford MW.

Ann Rheum Dis. 2018 Feb;77(2):241-250. doi: 10.1136/annrheumdis-2017-212141. Epub 2017 Oct 30.

15.

Do systematic reviews still exclude studies with "no relevant outcome data"?

Dwan KM, Williamson PR, Kirkham JJ.

BMJ. 2017 Aug 21;358:j3919. doi: 10.1136/bmj.j3919. No abstract available.

PMID:
28827402
16.

The COMET Handbook: version 1.0.

Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, Clarke M, Gargon E, Gorst S, Harman N, Kirkham JJ, McNair A, Prinsen CAC, Schmitt J, Terwee CB, Young B.

Trials. 2017 Jun 20;18(Suppl 3):280. doi: 10.1186/s13063-017-1978-4. Review.

18.

Citation analysis did not provide a reliable assessment of core outcome set uptake.

Barnes KL, Kirkham JJ, Clarke M, Williamson PR.

J Clin Epidemiol. 2017 Jun;86:153-159. doi: 10.1016/j.jclinepi.2017.03.003. Epub 2017 Mar 23.

19.

Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool.

Bracken LE, Nunn AJ, Kirkham JJ, Peak M, Arnott J, Smyth RL, Pirmohamed M, Turner MA.

PLoS One. 2017 Jan 3;12(1):e0169393. doi: 10.1371/journal.pone.0169393. eCollection 2017.

20.

Core Outcome Set-STAndards for Reporting: The COS-STAR Statement.

Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Moher D, Schmitt J, Tugwell P, Tunis S, Williamson PR.

PLoS Med. 2016 Oct 18;13(10):e1002148. doi: 10.1371/journal.pmed.1002148. eCollection 2016 Oct.

21.

How Much Participant Outcome Data Is Missing from Sight: Findings from a Cohort of Trials Submitted to a German Research Ethics Committee.

Kirkham JJ, Dwan KM, Blümle A, von Elm E, Williamson PR.

PLoS One. 2016 Jun 17;11(6):e0157883. doi: 10.1371/journal.pone.0157883. eCollection 2016.

22.

Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study.

Venkatesan S, Myles PR, McCann G, Kousoulis AA, Hashmi M, Belatri R, Boyle E, Barcroft A, van Staa TP, Kirkham JJ, Nguyen Van Tam JS, Williams TJ, Semple MG.

Health Technol Assess. 2015 Oct;19(89):1-132. doi: 10.3310/hta19890.

23.

COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).

Kirkham JJ, Gorst S, Altman DG, Blazeby J, Clarke M, Devane D, Gargon E, Williamson PR; COS-STAR Group.

Trials. 2015 Aug 22;16:373. doi: 10.1186/s13063-015-0913-9.

24.

The Importance of Integration of Stakeholder Views in Core Outcome Set Development: Otitis Media with Effusion in Children with Cleft Palate.

Harman NL, Bruce IA, Kirkham JJ, Tierney S, Callery P, O'Brien K, Bennett AM, Chorbachi R, Hall PN, Harding-Bell A, Parfect VH, Rumsey N, Sell D, Sharma R, Williamson PR.

PLoS One. 2015 Jun 26;10(6):e0129514. doi: 10.1371/journal.pone.0129514. eCollection 2015.

25.

Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use.

McCann LJ, Kirkham JJ, Wedderburn LR, Pilkington C, Huber AM, Ravelli A, Appelbe D, Williamson PR, Beresford MW.

Trials. 2015 Jun 12;16:268. doi: 10.1186/s13063-015-0784-0.

26.

A pilot randomised controlled trial to assess the utility of an e-learning package that trains users in adverse drug reaction causality.

Conroy EJ, Kirkham JJ, Bellis JR, Peak M, Smyth RL, Williamson PR, Pirmohamed M.

Int J Pharm Pract. 2015 Dec;23(6):447-55. doi: 10.1111/ijpp.12197. Epub 2015 May 29.

27.

National Audit of Seizure management in Hospitals (NASH): results of the national audit of adult epilepsy in the UK.

Dixon PA, Kirkham JJ, Marson AG, Pearson MG.

BMJ Open. 2015 Mar 31;5(3):e007325. doi: 10.1136/bmjopen-2014-007325.

28.

ADRIC: Adverse Drug Reactions In Children – a programme of research using mixed methods.

Smyth RL, Peak M, Turner MA, Nunn AJ, Williamson PR, Young B, Arnott J, Bellis JR, Bird KA, Bracken LE, Conroy EJ, Cresswell L, Duncan JC, Gallagher RM, Gargon E, Hesselgreaves H, Kirkham JJ, Mannix H, Smyth RMD, Thiesen S, Pirmohamed M.

Southampton (UK): NIHR Journals Library; 2014 Jun.

29.

Multivariate meta-analysis helps examine the impact of outcome reporting bias in Cochrane rheumatoid arthritis reviews.

Frosi G, Riley RD, Williamson PR, Kirkham JJ.

J Clin Epidemiol. 2015 May;68(5):542-50. doi: 10.1016/j.jclinepi.2014.11.017. Epub 2014 Nov 28.

PMID:
25537265
30.

Clinical coding of prospectively identified paediatric adverse drug reactions--a retrospective review of patient records.

Bellis JR, Kirkham JJ, Nunn AJ, Pirmohamed M.

BMC Pharmacol Toxicol. 2014 Dec 17;15:72. doi: 10.1186/2050-6511-15-72.

31.

Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews.

Saini P, Loke YK, Gamble C, Altman DG, Williamson PR, Kirkham JJ.

BMJ. 2014 Nov 21;349:g6501. doi: 10.1136/bmj.g6501.

32.

How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review.

Bautista-Molano W, Navarro-Compán V, Landewé RB, Boers M, Kirkham JJ, van der Heijde D.

Clin Rheumatol. 2014 Sep;33(9):1313-22. doi: 10.1007/s10067-014-2728-6. Epub 2014 Jun 28. Review.

PMID:
24970597
33.

Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials.

Dwan K, Altman DG, Clarke M, Gamble C, Higgins JP, Sterne JA, Williamson PR, Kirkham JJ.

PLoS Med. 2014 Jun 24;11(6):e1001666. doi: 10.1371/journal.pmed.1001666. eCollection 2014 Jun. Review.

34.

Dexamethasone and haemorrhage risk in paediatric tonsillectomy: a systematic review and meta-analysis.

Bellis JR, Pirmohamed M, Nunn AJ, Loke YK, De S, Golder S, Kirkham JJ.

Br J Anaesth. 2014 Jul;113(1):23-42. doi: 10.1093/bja/aeu152. Review.

35.

Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital.

Bellis JR, Kirkham JJ, Thiesen S, Conroy EJ, Bracken LE, Mannix HL, Bird KA, Duncan JC, Peak M, Turner MA, Smyth RL, Nunn AJ, Pirmohamed M.

BMC Med. 2013 Nov 7;11:238. doi: 10.1186/1741-7015-11-238.

36.

Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions.

Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, Duncan JC, Cresswell L, Kirkham JJ, Peak M, Williamson PR, Nunn AJ, Turner MA, Pirmohamed M, Smyth RL.

BMC Med. 2013 Nov 7;11:237. doi: 10.1186/1741-7015-11-237.

37.

Outcome measures in rheumatoid arthritis randomised trials over the last 50 years.

Kirkham JJ, Boers M, Tugwell P, Clarke M, Williamson PR.

Trials. 2013 Oct 9;14:324. doi: 10.1186/1745-6215-14-324. Review.

38.

Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension.

Hodkinson A, Kirkham JJ, Tudur-Smith C, Gamble C.

BMJ Open. 2013 Sep 27;3(9):e003436. doi: 10.1136/bmjopen-2013-003436.

39.

Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.

Bellis JR, Kirkham JJ, Nunn AJ, Pirmohamed M.

Br J Clin Pharmacol. 2014 Mar;77(3):545-53. doi: 10.1111/bcp.12222.

40.

Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review.

Dwan K, Gamble C, Williamson PR, Kirkham JJ; Reporting Bias Group.

PLoS One. 2013 Jul 5;8(7):e66844. doi: 10.1371/journal.pone.0066844. Print 2013. Review.

41.

Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis.

Dwan K, Kirkham JJ, Williamson PR, Gamble C.

BMJ Open. 2013 Jun 20;3(6). pii: e002709. doi: 10.1136/bmjopen-2013-002709.

42.

Can a core outcome set improve the quality of systematic reviews?--a survey of the Co-ordinating Editors of Cochrane Review Groups.

Kirkham JJ, Gargon E, Clarke M, Williamson PR.

Trials. 2013 Jan 22;14:21. doi: 10.1186/1745-6215-14-21.

43.

Cross-sectional study of prescribing errors in patients admitted to nine hospitals across North West England.

Seden K, Kirkham JJ, Kennedy T, Lloyd M, James S, McManus A, Ritchings A, Simpson J, Thornton D, Gill A, Coleman C, Thorpe B, Khoo SH.

BMJ Open. 2013 Jan 9;3(1). pii: e002036. doi: 10.1136/bmjopen-2012-002036.

44.

Adverse drug reactions causing admission to a paediatric hospital.

Gallagher RM, Mason JR, Bird KA, Kirkham JJ, Peak M, Williamson PR, Nunn AJ, Turner MA, Pirmohamed M, Smyth RL.

PLoS One. 2012;7(12):e50127. doi: 10.1371/journal.pone.0050127. Epub 2012 Dec 4.

45.

The reporting of harms in randomized controlled trials of hypertension using the CONSORT criteria for harm reporting.

Bagul NB, Kirkham JJ.

Clin Exp Hypertens. 2012;34(8):548-54. doi: 10.3109/10641963.2012.681724. Epub 2012 May 9. Review.

PMID:
22571478
46.

A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviews.

Kirkham JJ, Riley RD, Williamson PR.

Stat Med. 2012 Sep 10;31(20):2179-95. doi: 10.1002/sim.5356. Epub 2012 Apr 25.

PMID:
22532016
47.

Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool.

Gallagher RM, Kirkham JJ, Mason JR, Bird KA, Williamson PR, Nunn AJ, Turner MA, Smyth RL, Pirmohamed M.

PLoS One. 2011;6(12):e28096. doi: 10.1371/journal.pone.0028096. Epub 2011 Dec 14.

48.

Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists.

Smyth RM, Kirkham JJ, Jacoby A, Altman DG, Gamble C, Williamson PR.

BMJ. 2011 Jan 6;342:c7153. doi: 10.1136/bmj.c7153.

49.

Bias due to changes in specified outcomes during the systematic review process.

Kirkham JJ, Altman DG, Williamson PR.

PLoS One. 2010 Mar 22;5(3):e9810. doi: 10.1371/journal.pone.0009810.

50.

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews.

Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, Williamson PR.

BMJ. 2010 Feb 15;340:c365. doi: 10.1136/bmj.c365.

PMID:
20156912

Supplemental Content

Loading ...
Support Center